http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html <p> NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of http://www.streetinsider.com/Press+Releases/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html Fri, 14 Aug 2026 08:30:00 -0400 O.46871614 SDGR http://www.streetinsider.com/Press+Releases/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html <p> NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of http://www.streetinsider.com/Press+Releases/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html Fri, 14 Aug 2026 08:30:00 -0400 O.46871614 SDGR http://www.streetinsider.com/Business+Wire/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html <p> NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of http://www.streetinsider.com/Business+Wire/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html Fri, 14 Aug 2026 08:30:00 -0400 O.46871614 SDGR http://www.streetinsider.com/Business+Wire/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html <p> NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of http://www.streetinsider.com/Business+Wire/Schr%C3%B6dinger+Reports+Inducement+Grants+under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26925105.html Fri, 14 Aug 2026 08:30:00 -0400 O.46871614 SDGR http://www.streetinsider.com/New+Coverage/UBS+Starts+Schrodinger+%28SDGR%29+at+Neutral/26923631.html <p>UBS analyst Kevin Caliendo initiates coverage on Schrodinger (NASDAQ: SDGR) with a Neutral rating and a price target of $19.00.</p><p>The analyst comments "We assume coverage of SDGR at Neutral with a $19 price target. We believe the market is currently pricing in a 3-yr Software growth CAGR of ~15% (FY26-FY29) with EBITDA turning positive by FY28. We are forecasting ~16% Software growth over that period, but with a lack of clear catalysts over the next 12 months, we would like to see SDGR's transition to a software-centric, drug discovery model gain traction before potentially taking an active view on shares. http://www.streetinsider.com/New+Coverage/UBS+Starts+Schrodinger+%28SDGR%29+at+Neutral/26923631.html Fri, 14 Aug 2026 05:51:56 -0400 SDGR http://www.streetinsider.com/Analyst+Comments/UBS+Starts+Schrodinger+%28SDGR%29+at+Neutral/26923631.html <p>UBS analyst Kevin Caliendo initiates coverage on Schrodinger (NASDAQ: SDGR) with a Neutral rating and a price target of $19.00.</p><p>The analyst comments "We assume coverage of SDGR at Neutral with a $19 price target. We believe the market is currently pricing in a 3-yr Software growth CAGR of ~15% (FY26-FY29) with EBITDA turning positive by FY28. We are forecasting ~16% Software growth over that period, but with a lack of clear catalysts over the next 12 months, we would like to see SDGR's transition to a software-centric, drug discovery model gain traction before potentially taking an active view on shares. http://www.streetinsider.com/Analyst+Comments/UBS+Starts+Schrodinger+%28SDGR%29+at+Neutral/26923631.html Fri, 14 Aug 2026 05:51:56 -0400 SDGR http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Earnings/Schrodinger+Inc.+%28SDGR%29+Tops+Q2+EPS+by+57c/26875188.html <p>Schrodinger Inc. (NASDAQ: SDGR) reported Q2 EPS of $0.08, $0.57 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $58.89 million versus the consensus estimate of $48.08 million.</p><p>For earnings history and earnings-related data on Schrodinger Inc. (SDGR) <a href="http://www.streetinsider.com/ec_earnings.php?q=SDGR">click here</a>.</p> http://www.streetinsider.com/Earnings/Schrodinger+Inc.+%28SDGR%29+Tops+Q2+EPS+by+57c/26875188.html Wed, 05 Aug 2026 16:36:47 -0400 SDGR http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Schrodinger%2C+Inc.++++++++++++++++++++/26874769.html si-local-file:///var/storage/secattach/20260805/26874769.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Schrodinger%2C+Inc.++++++++++++++++++++/26874769.html Wed, 05 Aug 2026 16:21:00 -0400 O.46871614 SDGR http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Schrodinger%2C+Inc.++++++++++++++++++++/26874769.html si-local-file:///var/storage/secattach/20260805/26874769.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Schrodinger%2C+Inc.++++++++++++++++++++/26874769.html Wed, 05 Aug 2026 16:21:00 -0400 O.46871614 SDGR http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Schrodinger%2C+Inc.+++++++++For%3A+Aug+05/26874186.html si-local-file:///var/storage/secattach/20260805/26874186.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Schrodinger%2C+Inc.+++++++++For%3A+Aug+05/26874186.html Wed, 05 Aug 2026 16:09:00 -0400 O.46871614 SDGR http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Schrodinger%2C+Inc.+++++++++For%3A+Aug+05/26874186.html si-local-file:///var/storage/secattach/20260805/26874186.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Schrodinger%2C+Inc.+++++++++For%3A+Aug+05/26874186.html Wed, 05 Aug 2026 16:09:00 -0400 O.46871614 SDGR http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Schrodinger%2C+Inc.+++++++++For%3A+Jun+30/26874221.html si-local-file:///var/storage/secattach/20260805/26874221.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Schrodinger%2C+Inc.+++++++++For%3A+Jun+30/26874221.html Wed, 05 Aug 2026 16:09:00 -0400 O.46871614 SDGR http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Schrodinger%2C+Inc.+++++++++For%3A+Jun+30/26874221.html si-local-file:///var/storage/secattach/20260805/26874221.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Schrodinger%2C+Inc.+++++++++For%3A+Jun+30/26874221.html Wed, 05 Aug 2026 16:09:00 -0400 O.46871614 SDGR